This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aorticvalve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4
Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aorticvalve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates.
Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality. Aim This study aimed to systematically review and analyse the existing evidence on outcomes of emergency transcatheter aorticvalve implantation (eTAVI) and emergency balloon aortic valvuloplasty (eBAV) in CS patients.
The patient, diagnosed with obstructive hypertrophic cardiomyopathy, underwent left ventricular outflow tract surgery before visiting our hospital. Although enzyme replacement therapy (ERT) was initiated immediately after diagnosis, the patient experienced aorticvalve damage and left heart enlargement 2 years later.
After 24 hours, the patient was readmitted to the hospital with chest pain and troponin elevation, without ECG changes. A transthoracic echocardiogram (TTE) revealed a mobile mass on the right coronary cusp of the aorticvalve ( figure 1 , ). Figure 1 A mobile mass (1.88
Data shows, versus surgery, the Evolut transcatheter aorticvalve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years, strong valve performance and durable clinical outcomes. Reardon, M.D.,
A normal functioning aorticvalve has three leaflets, usually referred to as cusps, and is positioned at the end of the left ventricle. This valve is the main pump that delivers oxygenated blood to the entire body. Today we take a deep dive into aorticvalve replacement, so you can have the knowledge you need.
milla1cf Mon, 12/18/2023 - 15:43 December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest possible three-star recognition in all of the cardiac surgery categories in the 2020-2023 Society of Thoracic Surgeons (STS) report. The Mount Sinai Hospital is also No.
This study aimed to evaluate the early and mid-term outcomes of transcatheter closure using a double-disc occluder device in a single-center Vietnamese cohort.MethodA prospective descriptive study was conducted at Hanoi Heart Hospital, Vietnam. Data were analyzed using SPSS 20.0.ResultsThe
Patient selection was based on the presence of isolated aorticvalve disease without the need for ascending aorta replacement or aortic root enlargement. The majority of patients (77.1%) presented with aortic stenosis, often accompanied by severe calcification. years, with 22.9% being female.
BackgroundThe widely used Bentall procedure is the criterion standard treatment for aortic root pathology. Among these patients, 351 (33.4%) and 701 (66.6%) chose bioprosthetic and mechanical valves, respectively. Journal of the American Heart Association, Ahead of Print. 1.19];P=0.716) and all‐cause mortality (34.1%
ResultsThe overall in-hospital mortality was 1,7%. There were no statistically significant differences in terms of stroke, paravalvular leak, mechanical ventilation time, blood transfusion requirements, pacemaker implantation, reexploration for bleeding, conversion, wound infection, or in-hospital stay.
Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported it has reached a significant milestone of performing over 5,000 transcatheter aorticvalve replacement (TAVR) procedures, the first in New Jersey and among the first to accomplish this in the United States.
The cardiothoracic surgery programs at four Northwell Health hospitals received this distinguished accolade, showcasing their commitment to delivering exceptional care and achieving outstanding outcomes. The STS star rating system is renowned as one of the most sophisticated and highly regarded measures of quality in healthcare nationally.
Fethi Benraouane , and Dr. Molham Aldeiri , have successfully performed the first series of transcarotid Transcatheter AorticValve Replacement (TAVR) procedures ever done in Southeast Houston. This novel approach potentially decreases the risk of stroke and vascular complications and makes more options available for patients.
In patients undergoing transcatheter aorticvalve replacement (TAVR), the risk of delayed atrioventricular block (AVB) in those without procedural conduction disturbances (CDs) remains largely unknown. This may impact hospital stay, particularly same- or next-day discharge following the procedure.
We estimate the relationship between local deprivation ranking and differences in volumes of aorticvalve replacement, which include transcatheter aorticvalve replacement (TAVR) and surgical aorticvalve replacement (SAVR), versus coronary artery bypass graft surgery and laparoscopic colectomy (LC).
Three months later, a transapical beating-heart septal myectomy (TA-BSM) was performed in our hospital. TA-BSM is a minimally invasive, safe, and effective surgical procedure for ameliorating LVOTO in patients with aorticvalve prostheses.
After bioprosthetic aorticvalve replacement, patients who took the oral drug warfarin had better outcomes including lower mortality rates and fewer blood clots, according to new research from Rochester, Minn.-based based Mayo Clinic.
BACKGROUND:Data concerning the outcomes of transcatheter aorticvalve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2% 2.44];P=0.035).
Objective The association between a combined anaemia and renal failure index and 1-year prognosis of patients undergoing transcatheter aorticvalve implantation (TAVI) is unexplored. Trial registration number 4143 (The Institutional Review Board of Kurashiki Central Hospital)
Transcatheter aorticvalve replacement (TAVR) is increasing in popularity for symptomatic severe aortic stenosis. Transfemoral arterial route is the most commonly used approach for TAVR, also known as TAVI or transcatheter aorticvalve implantation. JACC: Asia. May 14, 2024. Epublished DOI: 10.1016/j.jacasi.2024.03.006
The DAIC team has learned of the passing of Alain Cribier, MD, FACC, heralded as the man who pioneered the first transcatheter aorticvalve replacement (TAVR) in 2002, as well as the first transcatheter mitral commissurotomy in 1995 and the first balloon aortic valvuloplasty in 1986. He passed away Feb.
Background Aortic stenosis is a life-limiting condition for which transcatheter aorticvalve implantation (TAVI) is an established therapy. Objectives We sought to examine the association of coexistent CAD on mortality and hospital readmission in patients undergoing TAVI.
An 84-year-old woman was referred for transcatheter aorticvalve replacement (TAVR) following severe symptomatic aortic stenosis (valve area 0.9 cm2, peak and mean transaortic pressure gradients of 63 and 32 mmHg, respectively).
The academic medical centers received three-star ratings in isolated coronary artery bypass grafting (CABG) and isolated mitral valve replacement and repair (MVRR) surgeries. Jersey Shore University Medical Center also received a three-star rating in isolated aorticvalve replacement (AVR) surgery. and Canada.
BackgroundWhether a bovine or porcine aorticvalve bioprosthesis carries a higher risk of endocarditis after aorticvalve replacement is unknown. The primary outcome was prosthetic valve endocarditis, and the secondary outcomes were all‐cause mortality and early prosthetic valve endocarditis.
Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aorticvalve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes.
BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aorticvalve replacement (SAVR) in patients with bicuspid aorticvalve (BAV) aortic stenosis (AS) versus patients with tricuspid aorticvalve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).
Background and aims Randomised controlled trials comparing transcatheter aorticvalve replacement (TAVR) and surgical aorticvalve replacement (SAVR) were performed in highly selected populations and data regarding long-term secondary complications beyond mortality are scarce.
BACKGROUND:The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aorticvalve replacement (AVR). Patients were categorized into 5 groups (stages 04) based on their stage of cardiac damage in the year before AVR.
Presentation title: QUALITY OF LIFE ASSESSMENT AT 30-DAYS FOLLOW-UP OF THE VALVOSOFT PIVOTAL STUDY ON SEVERE AORTICVALVE STENOSE PATIENTS" (control number 16930) Time and date: April 8, 2024 - 9:32 a.m.–9:42 A summary of the poster session will be published on the Journal of the American College of Cardiology’s website.
A nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) who underwent transcatheter aorticvalve replacement (TAVR) or surgical aorticvalve replacement (SAVR) determined that patients who underwent TAVR had lower in-hospital complications and resource utilization compared with SAVR.
If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. Understanding Aortic Stenosis The aorticvalve regulates blood flow from your heart’s main pumping chamber to the rest of your body. In aortic stenosis, the valve leaflets stiffen and narrow, restricting blood flow.
Objective To assess gender, ethnicity, and deprivation-based differences in provision of aorticvalve replacement (AVR) in England for adults with aortic stenosis (AS).
BACKGROUND:Patients with paradoxical low-flow, low-gradient severe aortic stenosis exhibit low transvalvular flow rate (Q), while maintaining preserved left ventricular ejection fraction. Over a follow-up of up to 5 years, severe MR correlated with higher all-cause mortality (P=0.02) and aorticvalve replacement rates (P=0.012).
Background:The optimal treatment in patients with severe aortic stenosis (AS) and small aortic annulus (SAA) remains to be determined. Participants were 151 patients with severe AS and SAA (mean diameter <23 mm) were randomized (1:1) to TAVR (n=77) vs SAVR (n=74), The primary outcome was impaired valve hemodynamics (i.e.
In a randomized trial, the routine use of cerebral embolic protection during TAVI did not reduce the incidence of stroke within 72 hours or before discharge from the hospital (if discharge occurred sooner).
Is there a relationship between site-level volumes and outcomes for transcatheter aorticvalve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER)?
Webinar Latin Heart Rounds Series: Rounds on a Patient with Ascending Aortic Aneurysm and Arch Involvement dkaczmarek Wed, 10/11/2023 - 11:22 December 15, 2023 Image Join us on December 15, when experts will provide up-to-date insight on the management of patients with aortic root and ascending aortic aneurysm involving the aortic arch.
Background:Peak aorticvalve Doppler velocity, mean aorticvalve gradient, and Doppler estimated aorticvalve area are key measures recommended for assessing aortic stenosis severity. Failure to accurately diagnose severe aortic stenosis is critical.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content